About the Company - Advanced Enzyme Technologies Ltd
Advanced Enzyme Technologies Ltd. is a Public Limited Listed company incorporated on 15/03/1989 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24200MH1989PLC051018 and registration number is 051018. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 272.80 Cr. and Equity Capital is Rs. 22.36 Cr. for the Year ended 31/03/2022.
| Management |
|---|
| Name | Position Held |
|---|
| Mr. Vasant Rathi | Non Executive Chairman |
| Mr. Mukund M Kabra | Whole Time Director |
| Ms. Rasika Rathi | Non Executive Director |
| Dr. Sunny Sharma | Non Executive Director |
| Mr. Pramod Kasat | Independent Director |
| Mrs. Vandana Tilak | Independent Director |
| Ms. Rajshree Patel | Independent Director |
| Mr. Nitin Desmukh | Independent Director |
| Mr. Vinodkumar Jajoo | Independent Director |
Basic Stock Data of Advanced Enzyme Technologies Ltd
Last Updated: July 6, 2024, 12:26 pm
| Market Cap | 4,464 Cr. |
|---|
| Current Price | 399 |
|---|
| High / Low | 425/280 |
|---|
| Stock P/E | 31.0 |
|---|
| Book Value | 118 |
|---|
| Dividend Yield | 1.28 % |
|---|
| ROCE | 15.2 % |
|---|
| ROE | 11.2 % |
|---|
| Face Value | 2.00 |
|---|
| PEG Ratio | 26.63 |
|---|
Advanced Enzyme Technologies Ltd Quarterly Results
Advanced Enzyme Technologies Ltd Quarterly Chart
Advanced Enzyme Technologies Ltd Profit & Loss
Last Updated: May 30, 2024, 10:40 pm
| Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
|---|
| Sales | 171 | 219 | 239 | 222 | 293 | 329 | 391 | 420 | 444 | 502 | 529 | 541 | 605 |
| Expenses | 109 | 130 | 189 | 131 | 155 | 177 | 226 | 236 | 241 | 269 | 327 | 382 | 412 |
| Operating Profit | 62 | 90 | 50 | 91 | 138 | 152 | 165 | 184 | 203 | 233 | 203 | 158 | 193 |
| OPM % | 36% | 41% | 21% | 41% | 47% | 46% | 42% | 44% | 46% | 46% | 38% | 29% | 32% |
| Other Income | 3 | 4 | 1 | 1 | -3 | 3 | 1 | 5 | 6 | 9 | 6 | 21 | 34 |
| Interest | 12 | 10 | 13 | 9 | 8 | 4 | 9 | 5 | 4 | 3 | 3 | 3 | 3 |
| Depreciation | 6 | 8 | 10 | 9 | 9 | 13 | 18 | 21 | 26 | 29 | 35 | 35 | 34 |
| Profit before tax | 48 | 76 | 28 | 74 | 118 | 137 | 139 | 162 | 179 | 210 | 171 | 140 | 190 |
| Tax % | 29% | 34% | 23% | 31% | 35% | 32% | 33% | 28% | 26% | 28% | 28% | 26% | |
| Net Profit | 34 | 50 | 21 | 51 | 77 | 93 | 94 | 116 | 133 | 151 | 124 | 104 | 139 |
| EPS in Rs | 3.22 | 4.52 | 1.85 | 4.60 | 6.97 | 8.20 | 8.07 | 9.95 | 11.58 | 13.06 | 10.70 | 9.45 | 12.27 |
| Dividend Payout % | 1% | 7% | 6% | 4% | 3% | 5% | 6% | 6% | 5% | 7% | 9% | 11% | |
Advanced Enzyme Technologies Ltd Profit & Loss Yearly Chart
Advanced Enzyme Technologies Ltd Growth
|
| Compounded Sales Growth |
|---|
| 10 Years: | 10% |
| 5 Years: | 8% |
| 3 Years: | 8% |
| TTM: | 15% |
|
| Compounded Profit Growth |
|---|
| 10 Years: | 22% |
| 5 Years: | 5% |
| 3 Years: | 0% |
| TTM: | 34% |
|
| Stock Price CAGR |
|---|
| 10 Years: | % |
| 5 Years: | 18% |
| 3 Years: | -2% |
| 1 Year: | 44% |
|
| Return on Equity |
|---|
| 10 Years: | 15% |
| 5 Years: | 13% |
| 3 Years: | 11% |
| Last Year: | 11% |
Last Updated: June 18, 2024, 6:20 am
Advanced Enzyme Technologies Ltd Balance Sheet
| Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 |
|---|
| Equity Capital | 21 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 |
| Reserves | 75 | 140 | 145 | 188 | 256 | 442 | 537 | 657 | 817 | 949 | 1,066 | 1,213 | 1,226 |
| Borrowings | 207 | 186 | 167 | 115 | 101 | 54 | 67 | 35 | 28 | 28 | 35 | 34 | 39 |
| Other Liabilities | 46 | 48 | 73 | 92 | 71 | 65 | 102 | 91 | 104 | 150 | 137 | 142 | 157 |
| Total Liabilities | 349 | 396 | 406 | 417 | 450 | 583 | 727 | 805 | 971 | 1,149 | 1,260 | 1,411 | 1,444 |
| Fixed Assets | 204 | 287 | 287 | 287 | 285 | 421 | 491 | 495 | 563 | 604 | 619 | 649 | 653 |
| CWIP | 60 | 2 | 2 | 5 | 7 | 8 | 11 | 10 | 10 | 10 | 15 | 22 | 17 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 111 | 124 | 121 | 102 | 360 | 342 |
| Other Assets | 84 | 107 | 117 | 125 | 158 | 153 | 226 | 188 | 275 | 414 | 524 | 380 | 432 |
| Total Assets | 349 | 396 | 406 | 417 | 450 | 583 | 727 | 805 | 971 | 1,149 | 1,260 | 1,411 | 1,444 |
Advanced Enzyme Technologies Ltd Reserves and Borrowings Chart
Advanced Enzyme Technologies Ltd Cash Flow
| Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|
| Cash from Operating Activity | 49 | 41 | 43 | 54 | 93 | 107 | 116 | 129 | 141 | 163 | 122 | 140 |
| Cash from Investing Activity | -187 | -40 | -25 | -15 | -10 | -60 | -60 | -124 | -43 | -27 | 2 | -286 |
| Cash from Financing Activity | 128 | -3 | -20 | -36 | -63 | -65 | -2 | -43 | -39 | -26 | -48 | -26 |
| Net Cash Flow | -10 | -2 | -1 | 2 | 21 | -18 | 54 | -38 | 60 | 109 | 75 | -171 |
|
Advanced Enzyme Technologies Ltd Financial Efficiency Indicators Chart
Advanced Enzyme Technologies Ltd Share Holding Pattern
| Month | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|
| Promoters | 52.30% | 52.55% | 52.71% | 52.70% | 52.70% | 49.88% | 49.88% | 49.88% | 46.52% | 45.92% | 43.62% | 43.50% |
| FIIs | 16.40% | 16.27% | 16.39% | 18.01% | 18.72% | 21.68% | 21.74% | 21.86% | 21.89% | 22.27% | 22.54% | 23.01% |
| DIIs | 8.46% | 8.66% | 8.99% | 6.90% | 6.26% | 5.60% | 5.64% | 5.73% | 7.58% | 6.49% | 6.98% | 7.56% |
| Public | 22.84% | 22.52% | 21.91% | 22.38% | 22.32% | 22.86% | 22.76% | 22.54% | 24.02% | 25.34% | 26.88% | 25.95% |
| No. of Shareholders | 79,254 | 87,112 | 84,346 | 86,573 | 84,376 | 84,277 | 81,183 | 77,537 | 75,052 | 72,642 | 73,034 | 68,640 |
Advanced Enzyme Technologies Ltd Shareholding Pattern Chart
No. of Advanced Enzyme Technologies Ltd Shareholders
Advanced Enzyme Technologies Ltd Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|
| HDFC Small Cap Fund - Regular Plan | 3,979,689 | 0.58 | 130.55 | 3,979,689 | 2024-07-05 | 0% |
| ICICI Prudential ESG Fund | 1,000,321 | 2.55 | 32.82 | 3,979,689 | 2024-07-05 | -74.86% |
| ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund | 860,609 | 0.89 | 28.23 | 3,979,689 | 2024-07-05 | -78.37% |
| ICICI Prudential Value Discovery Fund | 644,400 | 0.06 | 21.14 | 3,979,689 | 2024-07-05 | -83.81% |
| HDFC Multi Cap Fund | 507,664 | 0.2 | 16.65 | 3,979,689 | 2024-07-05 | -87.24% |
| ICICI Prudential Equity & Debt Fund | 115,918 | 0.02 | 3.8 | 3,979,689 | 2024-07-05 | -97.09% |
| Motilal Oswal S&P BSE Healthcare ETF | 388 | 0.16 | 0.01 | 3,979,689 | 2024-07-05 | -99.99% |
Advanced Enzyme Technologies Ltd ROCE Trend
Advanced Enzyme Technologies Ltd EPS Trend
Advanced Enzyme Technologies Ltd Key Financial Ratios
| Month | Mar 23 | Mar 22 | Mar 21 | Mar 20 | Mar 19 |
|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 9.45 | 10.70 | 13.09 | 11.58 | 9.95 |
| Diluted EPS (Rs.) | 9.45 | 10.68 | 13.07 | 11.56 | 9.94 |
| Cash EPS (Rs.) | 12.42 | 14.20 | 16.10 | 14.22 | 12.27 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 114.84 | 102.00 | 92.25 | 77.67 | 63.13 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 114.84 | 102.00 | 92.25 | 77.67 | 63.13 |
| Revenue From Operations / Share (Rs.) | 48.35 | 47.35 | 44.92 | 39.76 | 37.58 |
| PBDIT / Share (Rs.) | 16.27 | 18.59 | 21.51 | 18.62 | 16.74 |
| PBIT / Share (Rs.) | 13.13 | 15.46 | 18.97 | 16.31 | 14.85 |
| PBT / Share (Rs.) | 12.55 | 15.30 | 18.83 | 16.04 | 14.51 |
| Net Profit / Share (Rs.) | 9.29 | 11.07 | 13.56 | 11.91 | 10.38 |
| NP After MI And SOA / Share (Rs.) | 9.45 | 10.70 | 13.08 | 11.58 | 9.95 |
| PBDIT Margin (%) | 33.64 | 39.26 | 47.89 | 46.84 | 44.55 |
| PBIT Margin (%) | 27.16 | 32.65 | 42.23 | 41.03 | 39.52 |
| PBT Margin (%) | 25.96 | 32.31 | 41.91 | 40.35 | 38.60 |
| Net Profit Margin (%) | 19.21 | 23.38 | 30.18 | 29.96 | 27.62 |
| NP After MI And SOA Margin (%) | 19.53 | 22.58 | 29.13 | 29.12 | 26.46 |
| Return on Networth / Equity (%) | 8.55 | 10.98 | 15.06 | 15.39 | 16.35 |
| Return on Capital Employeed (%) | 10.92 | 14.31 | 19.53 | 19.94 | 22.39 |
| Return On Assets (%) | 7.42 | 9.43 | 12.68 | 13.21 | 13.69 |
| Long Term Debt / Equity (X) | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 |
| Total Debt / Equity (X) | 0.01 | 0.01 | 0.01 | 0.02 | 0.04 |
| Asset Turnover Ratio (%) | 0.33 | 0.32 | 0.38 | 0.40 | 0.40 |
| Current Ratio (X) | 9.31 | 10.00 | 7.64 | 5.85 | 4.07 |
| Quick Ratio (X) | 7.71 | 8.00 | 6.25 | 4.62 | 2.98 |
| Inventory Turnover Ratio (X) | 1.23 | 1.30 | 1.32 | 1.38 | 1.20 |
| Dividend Payout Ratio (NP) (%) | 10.58 | 8.41 | 4.58 | 5.18 | 5.02 |
| Dividend Payout Ratio (CP) (%) | 7.94 | 6.50 | 3.83 | 4.32 | 4.22 |
| Earning Retention Ratio (%) | 89.42 | 91.59 | 95.42 | 94.82 | 94.98 |
| Cash Earning Retention Ratio (%) | 92.06 | 93.50 | 96.17 | 95.68 | 95.78 |
| Interest Coverage Ratio (X) | 75.13 | 115.72 | 150.80 | 68.50 | 48.31 |
| Interest Coverage Ratio (Post Tax) (X) | 45.58 | 69.93 | 96.02 | 44.82 | 30.95 |
| Enterprise Value (Cr.) | 2529.42 | 2942.98 | 3729.91 | 1560.37 | 2073.02 |
| EV / Net Operating Revenue (X) | 4.68 | 5.56 | 7.43 | 3.51 | 4.94 |
| EV / EBITDA (X) | 13.91 | 14.16 | 15.52 | 7.50 | 11.09 |
| MarketCap / Net Operating Revenue (X) | 4.79 | 5.96 | 7.68 | 3.60 | 4.87 |
| Retention Ratios (%) | 89.41 | 91.58 | 95.41 | 94.81 | 94.97 |
| Price / BV (X) | 2.10 | 2.90 | 3.97 | 1.90 | 3.01 |
| Price / Net Operating Revenue (X) | 4.79 | 5.96 | 7.68 | 3.60 | 4.87 |
| EarningsYield | 0.04 | 0.03 | 0.03 | 0.08 | 0.05 |
Advanced Enzyme Technologies Ltd Profitability Ratios (%)
Advanced Enzyme Technologies Ltd Liquidity Ratios
Advanced Enzyme Technologies Ltd Liquidity Ratios (%)
Advanced Enzyme Technologies Ltd Interest Coverage Ratios (%)
Advanced Enzyme Technologies Ltd Valuation Ratios
Strength and Weakness of Advanced Enzyme Technologies Ltd Stock
Unable to fetch valid data for stock valuation.FAQ
What is the latest fair value of Advanced Enzyme Technologies Ltd?
The latest fair value of Advanced Enzyme Technologies Ltd is ₹0.00.
What is the Market Cap of Advanced Enzyme Technologies Ltd?
The Market Cap of Advanced Enzyme Technologies Ltd is 4,464 Cr..
What is the current Stock Price of Advanced Enzyme Technologies Ltd as on 06 July 2024?
The current stock price of Advanced Enzyme Technologies Ltd as on 06 July 2024 is 399.
What is the High / Low of Advanced Enzyme Technologies Ltd stocks in FY 2024?
In FY 2024, the High / Low of Advanced Enzyme Technologies Ltd stocks is 425/280.
What is the Stock P/E of Advanced Enzyme Technologies Ltd?
The Stock P/E of Advanced Enzyme Technologies Ltd is 31.0.
What is the Book Value of Advanced Enzyme Technologies Ltd?
The Book Value of Advanced Enzyme Technologies Ltd is 118.
What is the Dividend Yield of Advanced Enzyme Technologies Ltd?
The Dividend Yield of Advanced Enzyme Technologies Ltd is 1.28 %.
What is the ROCE of Advanced Enzyme Technologies Ltd?
The ROCE of Advanced Enzyme Technologies Ltd is 15.2 %.
What is the ROE of Advanced Enzyme Technologies Ltd?
The ROE of Advanced Enzyme Technologies Ltd is 11.2 %.
What is the Face Value of Advanced Enzyme Technologies Ltd?
The Face Value of Advanced Enzyme Technologies Ltd is 2.00.
Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a
SEBI registered financial advisor and does not have any vested interest in Advanced Enzyme Technologies Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source:
NSE 
